Medical journals and pharmaceutical companies: uneasy bedfellows
- 29 May 2003
- Vol. 326 (7400) , 1202-1205
- https://doi.org/10.1136/bmj.326.7400.1202
Abstract
Many medical journals have a substantial income from pharmaceutical companies from the purchasing of advertising and reprints and the sponsoring of supplements. Is this funding corrupting journals?Keywords
This publication has 8 references indexed in Scilit:
- Accuracy of pharmaceutical advertisements in medical journalsThe Lancet, 2003
- Congress criticises drugs industry for misleading advertisingBMJ, 2002
- Are randomised controlled trials in the BMJ different?BMJ, 2001
- Sponsorship, authorship, and accountabilityThe Lancet, 2001
- The Quality of Drug Studies Published in Symposium ProceedingsAnnals of Internal Medicine, 1996
- Evaluating the Quality of Articles Published in Journal Supplements Compared With the Quality of Those Published in the Parent JournalJAMA, 1994
- A Study of Manufacturer-Supported Trials of Nonsteroidal Anti-inflammatory Drugs in the Treatment of ArthritisArchives of internal medicine (1960), 1994
- Pharmaceutical Advertisements in Leading Medical Journals: Experts' AssessmentsAnnals of Internal Medicine, 1992